This was 2 years ago
Locationvirtual
ProgrammesThe European Innovation Council (EIC) and European Medicines Agency (EMA) are organising an Info Day. Participants will get to know the wide range of support services provided by EMA to researchers and SMEs active in research and innovation in the pharmaceutical and med-tech sectors. Speakers will talk about how to engage with EMA at different development milestones, and on the range of EMA support services. Benefits of the Innovation Task Force (ITF) services, PRIME and Scientific Advice, as well as practical details on how to prepare and submit applications, will be tackled. The event will entail testimonials from academic researchers and companies funded by the EIC Pathfinder and Accelerator programmes on their experience with EMA services.
EIC grantees and future EIC applicants are strongly encouraged to participate. The event is also open to researchers and SMEs funded by other EU programmes.
This event is relevant if:
The event is free of charge and no registration is required. The Info Day will be broadcasted on this web page
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 twinning project ScreenME has as its objective to enhance excellence in screen media entrepreneurship at Tallinn University (TLU). To do so, ScreenME has established a network of universities across Europe that aim to improve research into and teaching of entrepreneurship for the screen media industry. ScreenME will develop a teaching course and will kick off research initiatives and projects on entrepreneurial activities in media organisations. The research group on ‘Studies in Media, Innovation and Technology (SMIT)’ of the Vrije Universiteit Brussel (VUB) is partner in the network and is involved in two cross-cutting activities of the project: support for early stage researchers and developing stakeholder involvement.